감기 및 독감 보충제 시장 보고서(2026년)
Cold And Flu Supplements Global Market Report 2026
상품코드 : 1951631
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,777,000
PDF & Excel (Single User License) help
PDF & Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,796,000
PDF & Excel (Site License) help
PDF & Excel 보고서를 동일 기업의 동일 사업장 내의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,815,000
PDF & Excel (Enterprise License) help
PDF & Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

감기 및 독감 보충제 시장 규모는 최근 빠르게 확대하고 있습니다. 2025년 224억 3,000만 달러에서 2026년에는 252억 6,000만 달러로, CAGR 12.6%로 성장할 것으로 예상됩니다. 지금까지의 성장에는 면역 건강에 대한 소비자의 인식 증가, 전통적 약초 요법의 활용, 건강보조식품의 소매 채널 확대, 계절적 수요 사이클의 강세, 건강 지향적 라이프스타일의 확산 등이 주요 요인으로 꼽힙니다.

감기 및 독감 보충제 시장 규모는 향후 몇 년간 급속한 성장이 전망됩니다. 2030년에는 404억 달러에 달하고, CAGR은 12.5%가 될 전망입니다. 예측 기간 동안의 성장 요인으로는 헬스케어의 보급 확대, 셀프 케어에 대한 인식 증가, 온라인 보충제 판매의 성장, 천연 성분 배합의 혁신, 맞춤형 영양의 확대 등을 꼽을 수 있습니다. 예측 기간의 주요 동향으로는 면역력 향상 보충제 수요 확대, 허브 및 천연 성분 사용 증가, 예방적 건강관리 소비 확대, 일상적인 건강 유지 보충제 보급 확대, 클린 라벨 제품 및 유기농 제품 선호도 증가 등이 있습니다.

계절성 질환의 발생률 증가는 향후 몇 년 동안 감기 및 독감 보충제 시장의 성장을 촉진할 것으로 예상됩니다. 계절성 질환은 특정 시기에 자주 발생하는 질환으로, 보통 날씨, 기후, 환경적 요인의 변화에 영향을 받습니다. 기후변화로 인한 기온-습도 패턴의 변화가 감염 기간을 연장하고 독감 등 바이러스 확산을 촉진하고 있어 계절성 질환의 발생률이 증가하는 추세입니다. 감기 및 독감 보조제는 면역 기능 강화, 증상 완화, 감염으로부터의 조기 회복을 촉진하여 계절성 질환 관리에 도움을 줄 수 있습니다. 예를 들어, 2025년 1월 일본 비영리단체 '일본 커뮤니케이션 재단'의 발표에 따르면, 2024년 12월 일본의 독감 환자 수는 역대 최고치인 31만 7,812명에 달했다고 합니다. 이처럼 계절성 질환의 발생률 증가는 감기 및 독감 보조제 시장의 성장을 견인하고 있습니다.

감기 및 독감 보조제 시장의 주요 기업들은 하나의 처방약으로 여러 증상을 완화하는 올인원 복합증상 치료제 등 혁신적인 제품 개발에 주력하고 있습니다. 이를 통해 소비자의 편의성과 효과를 모두 향상시킬 수 있습니다. 올인원 복합증상치료제는 코막힘, 기침, 발열, 몸살 등 여러 가지 감기 및 독감증상을 한 번에 완화할 수 있도록 특별히 배합된 제품입니다. 예를 들어, 2024년 1월 영국 건강·위생·영양 제품 전문 기업 레킷벤키저 그룹(Reckitt Benckiser Group)은 빠른 효과와 청량감으로 아침 감기 및 독감증상을 완화하는 신제품 '패스트 맥스 킥스타트'를 출시했습니다. 이 혁신적인 제품은 코막힘, 인후통, 신체 통증을 빠르게 완화하는 속효성 성분을 함유하고 있어 편안한 하루를 시작할 수 있도록 도와줍니다. 또한, 독특한 청량감을 제공하고, 자극을 진정시키면서 상쾌한 경험을 선사합니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 이용 산업 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의가 공급망에 미치는 영향, 코로나가 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 시장에서 세계의 총 잠재 시장 규모(TAM)

제9장 시장 세분화

제10장 지역별, 국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자 환경

제36장 경쟁 구도와 기업 개요

제37장 기타 주요 기업과 혁신적 기업

제38장 세계의 시장 경쟁 벤치마킹과 대시보드

제39장 주요 인수합병

제40장 시장 잠재력이 높은 국가, 부문, 전략

제41장 부록

KSM
영문 목차

영문목차

Cold and flu supplements are dietary products designed to support the immune system and help relieve symptoms linked to colds and flu. They are used to enhance immunity, ease congestion, soothe sore throats, and aid overall recovery.

The primary offerings in cold and flu supplements include vitamins and minerals, herbal extracts, and natural molecules. Vitamins and minerals are crucial nutrients that aid in multiple bodily functions, such as supporting the immune system, promoting energy production, and facilitating cell repair. These supplements are available in various forms, including tablets and capsules, powders, syrups, and more, and are sold through multiple channels, such as pharmacies and drug stores, hypermarkets and supermarkets, online platforms, and others.

Tariffs have affected the cold and flu supplements market by increasing the cost of imported vitamins, minerals, herbal extracts, and natural active compounds used in immune-support products. These impacts have been most pronounced in herbal extract and natural molecule segments, particularly in north america and europe where sourcing is globally diversified. Asia-pacific producers have experienced pricing pressure due to raw material import dependencies. However, tariffs have promoted local sourcing of botanicals and domestic supplement manufacturing, supporting supply resilience.

The cold and flu supplements market research report is one of a series of new reports from The Business Research Company that provides cold and flu supplements market statistics, including cold and flu supplements industry global market size, regional shares, competitors with a cold and flu supplements market share, detailed cold and flu supplements market segments, market trends and opportunities, and any further data you may need to thrive in the cold and flu supplements industry. This cold and flu supplements market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cold and flu supplements market size has grown rapidly in recent years. It will grow from $22.43 billion in 2025 to $25.26 billion in 2026 at a compound annual growth rate (CAGR) of 12.6%. The growth in the historic period can be attributed to consumer awareness of immune health, traditional use of herbal remedies, expansion of dietary supplement retail channels, strong seasonal demand cycles, growth of wellness-focused lifestyles.

The cold and flu supplements market size is expected to see rapid growth in the next few years. It will grow to $40.4 billion in 2030 at a compound annual growth rate (CAGR) of 12.5%. The growth in the forecast period can be attributed to rising preventive healthcare adoption, increasing self-care awareness, growth of online supplement sales, innovation in natural formulations, expansion of personalized nutrition. Major trends in the forecast period include growing demand for immunity-boosting supplements, rising use of herbal and natural ingredients, expansion of preventive healthcare consumption, increased adoption of daily wellness supplements, preference for clean-label and organic products.

The increasing incidence of seasonal diseases is anticipated to drive the expansion of the cold and flu supplements market in the coming years. Seasonal diseases are conditions that appear more frequently at specific times of the year, usually influenced by shifts in weather, climate, or environmental factors. The incidence of seasonal diseases is rising, largely due to climate change, which modifies temperature and humidity patterns, prolonging transmission periods and facilitating the spread of viruses such as influenza. Cold and flu supplements assist in managing seasonal diseases by enhancing the immune system, alleviating symptom severity, and promoting faster recovery from infections. For example, in January 2025, the Nippon Communications Foundation, a Japan-based non-profit organization, reported that influenza cases in Japan reached a record high of 317,812 in December 2024. As a result, the rising incidence of seasonal diseases is fueling the growth of the cold and flu supplements market.

Major companies in the cold and flu supplements market are concentrating on creating innovative products, such as all-in-one multi-symptom remedies, to offer comprehensive relief by targeting multiple symptoms in a single formulation, improving both convenience and effectiveness for consumers. All-in-one multi-symptom remedies are specially formulated to alleviate several cold and flu symptoms at once, including congestion, cough, fever, and body aches, within a single dose. For example, in January 2024, Reckitt Benckiser Group plc, a UK-based company focused on health, hygiene, and nutrition products, introduced its new Fast-Max Kickstart aimed at relieving morning cold and flu symptoms with rapid-acting effects and a cooling sensation. This innovative product is distinguished by its fast-acting ingredients that promptly ease congestion, sore throat, and body aches, enabling users to begin their day comfortably. It also provides a distinctive cooling sensation, delivering a refreshing experience while calming irritation.

In September 2023, Sanofi S.A., a France-based pharmaceutical company, acquired Qunol LLC for $1.4 billion. Through this acquisition, Sanofi intends to enhance its consumer healthcare portfolio by broadening its presence in the wellness and dietary supplements market, capitalizing on Qunol's strong brand reputation in the heart health and immune support segments. Qunol LLC is a US-based company that produces immune support supplements designed to help prevent or relieve cold and flu symptoms.

Major companies operating in the cold and flu supplements market are Pfizer Inc., The Procter & Gamble Company, Johnson & Johnson, Bayer AG, Sanofi SA, Reckitt Benckiser Group plc, Haleon plc, Perrigo Company plc, Amway Corporation, Nu Skin Enterprises Inc., The Vitamin Shoppe Inc., NOW Health Group Inc., Nature's Sunshine Products Inc., Nature's Way Products LLC, Nordic Naturals Inc., Orthomol GmbH, Weefsel Pharma Pvt. Ltd., AdvaCare Pharma USA, Zarbee's Naturals LLC, Neurobiologix Inc.

North America was the largest region in the cold and flu supplements market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cold and flu supplements market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cold and flu supplements market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cold and flu supplements market consists of sales of effervescent tablets, lozenges, herbal teas, and nasal sprays. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cold And Flu Supplements Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses cold and flu supplements market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for cold and flu supplements ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cold and flu supplements market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

2. Cold And Flu Supplements Market Characteristics

3. Cold And Flu Supplements Market Supply Chain Analysis

4. Global Cold And Flu Supplements Market Trends And Strategies

5. Cold And Flu Supplements Market Analysis Of End Use Industries

6. Cold And Flu Supplements Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Cold And Flu Supplements Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

8. Global Cold And Flu Supplements Total Addressable Market (TAM) Analysis for the Market

9. Cold And Flu Supplements Market Segmentation

10. Cold And Flu Supplements Market Regional And Country Analysis

11. Asia-Pacific Cold And Flu Supplements Market

12. China Cold And Flu Supplements Market

13. India Cold And Flu Supplements Market

14. Japan Cold And Flu Supplements Market

15. Australia Cold And Flu Supplements Market

16. Indonesia Cold And Flu Supplements Market

17. South Korea Cold And Flu Supplements Market

18. Taiwan Cold And Flu Supplements Market

19. South East Asia Cold And Flu Supplements Market

20. Western Europe Cold And Flu Supplements Market

21. UK Cold And Flu Supplements Market

22. Germany Cold And Flu Supplements Market

23. France Cold And Flu Supplements Market

24. Italy Cold And Flu Supplements Market

25. Spain Cold And Flu Supplements Market

26. Eastern Europe Cold And Flu Supplements Market

27. Russia Cold And Flu Supplements Market

28. North America Cold And Flu Supplements Market

29. USA Cold And Flu Supplements Market

30. Canada Cold And Flu Supplements Market

31. South America Cold And Flu Supplements Market

32. Brazil Cold And Flu Supplements Market

33. Middle East Cold And Flu Supplements Market

34. Africa Cold And Flu Supplements Market

35. Cold And Flu Supplements Market Regulatory and Investment Landscape

36. Cold And Flu Supplements Market Competitive Landscape And Company Profiles

37. Cold And Flu Supplements Market Other Major And Innovative Companies

38. Global Cold And Flu Supplements Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Cold And Flu Supplements Market

40. Cold And Flu Supplements Market High Potential Countries, Segments and Strategies

41. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기